FDA approved five-membered ring fused pyrimidine-based derivatives and their biological properties

Simple item page
dc.contributor.authorKumar, Manvendra
dc.contributor.authorChatterjee, Joydeep
dc.contributor.authorRani, Dimpy
dc.contributor.authorKumar, Raj
dc.date.accessioned2024-01-21T10:38:26Z
dc.date.accessioned2024-08-13T12:05:22Z
dc.date.available2024-01-21T10:38:26Z
dc.date.available2024-08-13T12:05:22Z
dc.date.issued2022-10-14T00:00:00
dc.description.abstractPyrimidines-based drugs are one of the most important drugs for novel and recurring viruses, including the coronavirus. This chapter deals with 41 FDA-approved five-membered ring fused pyrimidine-based drugs, their synthetic strategies, and pharmacological activities. � 2023 Elsevier Ltd. All rights reserved.en_US
dc.identifier.doi10.1016/B978-0-443-18616-5.00006-5
dc.identifier.isbn9780443186165
dc.identifier.isbn9780443186172
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/3571
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/B9780443186165000065
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.subjectFDA approved drugsen_US
dc.subjectFive-membered ring fused pyrimidinesen_US
dc.subjectNucleosidesen_US
dc.subjectPDE5en_US
dc.subjectPharmacological activityen_US
dc.subjectSynthesisen_US
dc.titleFDA approved five-membered ring fused pyrimidine-based derivatives and their biological propertiesen_US
dc.title.journalFused Pyrimidine-Based Drug Discoveryen_US
dc.typeBook chapteren_US
dc.type.accesstypeClosed Accessen_US

Files

Collections

Pharmaceutical Sciences and Natural Products - Research Publications